Medecin
Official reprint from UpToDate® www.uptodate.com
Print | Back
| |[pic][pic]
|Print Options |
|Text |[pic] |
|References |[pic] |
|Graphics |[pic] |
|Risk of intracerebral hemorrhage in patients treated with warfarin |
|Author |
|Robert G Hart, MD |
|Section Editors |
|Lawrence LK Leung, MD |
|Jose Biller, MD, FACP, FAAN, FAHA |
|Deputy Editor |
|Stephen A Landaw, MD, PhD |
| |
| |
|Last literature review for version 17.3: septembre 30, 2009 | This topic last updated: février 6, 2009 |
INTRODUCTION — Antithrombotic therapies, including antiplatelet agents, heparin and related agents, oral vitamin K inhibitors, and direct thrombin inhibitors, are widely used in clinical medicine based upon well-designed randomized